7 months ago
CRVO
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 30%
#1481 out of 5080 analysts
Average Return
+7.28%
Win Rate
50%11 out of 22
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cervomed IncCRVO | +185.59% | $2.36 | $6.74 | 2025-03-11 - 2025-10-28 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-10 - 2025-10-07 | Strong Buy |
Avidity Biosciences IncRNA | +74.56% | $40.06 | $69.93 | 2025-09-17 - 2025-10-28 | Strong Buy |
Gain Therapeutics IncGANX | +23.87% | $1.55 | $1.92 | 2025-08-13 - 2025-10-28 | Strong Buy |
Longeveron IncLGVN | +22.24% | $0.76 | $0.93 | 2025-08-15 - 2025-10-28 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
8 months ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cingulate IncCING | 3 | Strong Buy | $17.00 | +367.03% | Maintains | 14 days ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $62.00 | -11.34% | Initiates Coverage On | a month ago |
Reviva Pharmaceuticals Holdings IncRVPH | 2 | Strong Buy | $3.00 | +419.93% | Reiterates | 2 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +222.93% | Maintains | 2 months ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +212.50% | Maintains | 3 months ago |
Cervomed IncCRVO | 4 | Strong Buy | $16.00 | +137.39% | Reiterates | 3 months ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $12.00 | +94.17% | Maintains | 4 months ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +8.50% | Reiterates | 4 months ago |
Polypid LtdPYPD | 2 | Strong Buy | $9.00 | +142.59% | Maintains | 4 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | +294.56% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.